Herb
Research Foundation News Archive |
|
Ephedra safety study in progress.
|
|
|
On June 12, the
Ephedra Research Foundation told FDA that acute phase results from industry-sponsored
safety research will be available by November 1. As of May 31, 59 of 150
mildly-to-severely overweight subjects had completed the study. All patients
were monitored for blood pressure increase, heart rate, and arrhythmia
after taking medication containing ephedra alkaloids and caffeine. The
foundation requested that FDA "delay the issuance of any final rule
or guidance document" on ephedra as a dietary supplement until the
agency has reviewed the results of this study. Research is currently under
way at Beth Israel-Deaconess Medical Center in Boston and St. Luke's-Roosevelt
Hospital in New York City. |
|
|
F-D-C- "The
Tan Sheet" July 13, 1998.
|
|
|
Back
to the HRF News Archive Table of Contents |